Journal For Immunotherapy Of CancerSCIE

本刊中國學者近年發表論文

• 1、Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation

  Author: Zhang, Biying; Li, Jiao; Hua, Qingling; Wang, Haihong; Xu, Guojie; Chen, Jiayuan; Zhu, Ying; Li, Ruiqi; Liang, Qing; Wang, Lanqing; Jin, Min; Tang, Jing; Lin, Zhenyu; Zhao, Lei; Zhang, Dejun; Yu, Dandan; Ren, Jinghua; Zhang, Tao

  Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005592

• 2、Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy

  Author: Tang, Rui; He, Hongye; Lin, Xiaohong; Wu, Nianhong; Wan, Li; Chen, Qiaoqi; Hu, Yaqin; Cheng, Chen; Cao, Yuting; Guo, Xun; Zhou, Ying; Xiong, Xialin; Zheng, Min; Wang, Qi; Li, Faqi; Zhou, Yang; Li, Pan

  Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-006226

• 3、Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy

  Author: Shi, Lin; Lu, Jinying; Zhong, Da; Song, Meijuan; Liu, Jian; You, Wenhua; Li, Wen-Hui; Lin, Lin; Shi, Dongyan; Chen, Yun

  Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005902

• 4、STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer

  Author: Ding, Liya; Wang, Qiwei; Martincuks, Antons; Kearns, Michael J.; Jiang, Tao; Lin, Ziying; Cheng, Xin; Qian, Changli; Xie, Shaozhen; Kim, Hye-Jung; Launonen, Inga-Maria; Faerkkilae, Anniina; Roberts, Thomas M.; Freeman, Gordon J.; Liu, Joyce F.; Konstantinopoulos, Panagiotis A.; Matulonis, Ursula; Yu, Hua; Zhao, Jean J.

  Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005627

• 5、Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy

  Author: Dai, Jie; Bai, Xue; Gao, Xuan; Tang, Lirui; Chen, Yu; Sun, Linzi; Wei, Xiaoting; Li, Caili; Qi, Zhonghui; Kong, Yan; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Xu, Zelong; Lian, Bin; Li, Siming; Yan, Xieqiao; Tang, Bixia; Zhou, Li; Wang, Xuan; Xia, Xuefeng; Guo, Jun; Mao, Lili; Si, Lu

  Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005937

• 6、New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

  Author: Bamias, Aristotelis; Merseburger, Axel; Loriot, Yohann; James, Nicholas; Choy, Ernest; Castellano, Daniel; Lopez-Rios, F.; Calabro, Fabio; Kramer, Mario; de Velasco, Guillermo; Zakopoulou, Roubini; Tzannis, Kimon; Sternberg, Cora N.

  Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005977

• 7、Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers

  Author: Ba, Hongping; Dai, Zigang; Zhang, Zunyue; Zhang, Peng; Yin, Bingjiao; Wang, Jing; Li, Zhuoya; Zhou, Xiaoxi

  Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2021-003837

• 8、Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases

  Author: Zhang, Chong; Wang, Xiang-Yu; Zuo, Jie-Liang; Wang, Xue-Fu; Feng, Xiao-Wen; Zhang, Bo; Li, Yi-Tong; Yi, Chen-He; Zhang, Peng; Ma, Xiao-Chen; Chen, Zhen-Mei; Ma, Yue; Han, Jia-Hao; Tao, Bao-Rui; Zhang, Rui; Wang, Tian-Qi; Tong, Li; Gu, Wang; Wang, Si-Yu; Zheng, Xiao-Fei; Yuan, Wen-Kang; Kan, Zi-Jie; Fan, Jie; Hu, Xiang-Yang; Li, Jun; Zhang, Chao; Chen, Jin-Hong

  Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 2, pp. -. DOI: 10.1136/jitc-2022-006425